ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Pulmonary Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,866Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 120

$1.85M Total Retail Price of All Prescriptions

Rank: 1 out of 120

699 Patients Receiving at Least One Drug in Part D
87% Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Connecticut
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

14% of this provider’s 699 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

5% of this provider’s 699 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 60%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $173 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
FUROSEMIDE 1,214 1,156 145 1 7
METOPROLOL TARTRATE 674 625 97 2 15
LEVOTHYROXINE SODIUM 660 627 96 3 10
AMLODIPINE BESYLATE 648 637 93 4 11
WARFARIN SODIUM 645 595 46 5 16
OMEPRAZOLE 556 498 98 6 12
CYMBALTA 546 494 35 7 29
LISINOPRIL 543 506 88 8 13
ATORVASTATIN CALCIUM 536 488 82 9 9
SIMVASTATIN 514 487 85 10 8
TRAZODONE HCL 488 472 65 11 33
POTASSIUM CHLORIDE 445 427 57 12 27
ESCITALOPRAM OXALATE 430 425* 40 13 26
DONEPEZIL HCL 427 415 47 14 36
LORAZEPAM 390 331 78 B 15 36
QUETIAPINE FUMARATE 389 363 40 A 16 35
SERTRALINE HCL 382 368 40 17 39
CITALOPRAM HBR 353 339 43 18 46
ADVAIR DISKUS 347 312 80 19 2
GABAPENTIN 335 312 45 20 28
NAMENDA 320 320 24 21 47
SPIRIVA 294 248 65 22 1
MIRTAZAPINE 289 264 43 23 48
METFORMIN HCL 255 221 42 24 20
CLOPIDOGREL 249 235 31 25 38
RISPERIDONE 236 200 26 A 26 61
DIOVAN 236 231* 24 26 41
PREDNISONE 231 190 83 28 5
METOPROLOL SUCCINATE 218 218 30 29 23
ALPRAZOLAM 215 165 34 B 30 30
GLIPIZIDE 214 214 34 31 55
HYDROCHLOROTHIAZIDE 210 185 30 32 18
ABILIFY 205 205 12 A 33 75
ATENOLOL 188 188 36 34 25
MONTELUKAST SODIUM 188 166 37 34 3
OLANZAPINE 187 187 17 A 36 78
ALLOPURINOL 186 168 32 37 45
IPRATROPIUM-ALBUTEROL 184 179* 53 38 64
PROAIR HFA 180 107 52 39 4
LANTUS 173 162 34 40 53
VESICARE 172 160 15 41 81
NEXIUM 168 143 24 42 32
TAMSULOSIN HCL 168 142 34 42 43
DIVALPROEX SODIUM 162 126 16 44 83
LOSARTAN POTASSIUM 162 157* 24 44 34
OXYCODONE-ACETAMINOPHEN 161 115 42 S2 46 56
CRESTOR 161 156* 22 46 40
JANTOVEN 159 <11 <11 48 85
HUMALOG 159 143 28 48 85
CARVEDILOL 155 150* 22 50 51
ZOLPIDEM TARTRATE 151 119 35 51 22
DIGOX 149 144* 26 52 74
PANTOPRAZOLE SODIUM 143 124 32 53 24
JANUVIA 136 122 15 54 62
ISOSORBIDE MONONITRATE ER 131 131 19 55 78
PHENYTOIN SODIUM EXTENDED 126 85 13 56 99
ZETIA 126 115 13 56 99
CELEBREX 116 111* 16 58 66
TRAMADOL HCL 115 88 31 59 44
GLYBURIDE 107 102* 23 R 60 80
RIVASTIGMINE 105 <11 <11 61 108
KLOR-CON M20 103 91 23 62 65
ROPINIROLE HCL 102 97* 14 63 76
AMOX TR-POTASSIUM CLAVULANATE 101 86 71 64 87
ALENDRONATE SODIUM 93 88* 14 65 70
LYRICA 93 75 13 65 113
LEVOFLOXACIN 93 78 70 65 60
VALSARTAN-HYDROCHLOROTHIAZIDE 90 77 18 68 90
OXYCODONE HCL 89 73 25 S2 69 89
AMOXICILLIN 89 76 69 69 73
DILTIAZEM 24HR CD 88 83* 12 71 114
CLONAZEPAM 87 82* 15 B 72 84
OXYBUTYNIN CHLORIDE ER 85 <11 <11 73 117
LATANOPROST 85 85 11 73 117
SPIRONOLACTONE 85 <11 <11 73 67
ENOXAPARIN SODIUM 83 83 14 76 120
LIDODERM 82 77* 15 77 95
LANSOPRAZOLE 82 77* 12 77 121
CEPHALEXIN 82 70 54 77 121
HYDROCODONE-ACETAMINOPHEN 78 56 24 S3 80 58
ENABLEX 78 <11 <11 80 124
TOPIRAMATE 76 <11 <11 82 126
PAROXETINE HCL 76 <11 <11 82 92
RANITIDINE HCL 74 69* 18 84 127
FINASTERIDE 73 61 12 85 128
SYMBICORT 73 68* 20 85 6
LEVETIRACETAM 72 <11 <11 87 129
CIPROFLOXACIN HCL 71 59 56 88 88
FENOFIBRATE* 71 <11 <11 88 92
CARBIDOPA-LEVODOPA 70 <11 <11 90 102
FENTANYL 70 58 14 S2 90 97
FLUTICASONE PROPIONATE 68 46 26 92 19
NOVOLIN R 68 63* 16 92 133
FENOFIBRATE* 67 <11 <11 94 92
DILTIAZEM 24HR ER 66 61* 15 95 135
SEROQUEL XR 66 <11 <11 A 95 135
PHENYTOIN 66 <11 <11 95 135
HALOPERIDOL 65 <11 <11 A 98 141
OXYCONTIN 64 <11 <11 S2 99 144
FLUOXETINE HCL 63 <11 <11 100 106
NITROGLYCERIN PATCH 63 <11 <11 100 146
PRAVASTATIN SODIUM 63 58* 12 100 57
BUPROPION XL 60 <11 <11 103 148
LAMOTRIGINE 60 <11 <11 103 148
NOVOLOG 58 <11 <11 105 152
FAMOTIDINE* 57 <11 <11 106 153
ENALAPRIL MALEATE 57 52* 15 106 102
NIFEDIPINE ER 54 <11 <11 108 158
CLOTRIMAZOLE-BETAMETHASONE 53 48* 33 109 160
BACLOFEN 53 <11 <11 109 160
PHENOBARBITAL 52 <11 <11 R 111 166
DOXYCYCLINE HYCLATE 50 45* 29 112 62
ONDANSETRON HCL* 50 45* 20 112 174
VERAPAMIL ER 50 45* 11 112 174
MELOXICAM 50 <11 <11 112 174
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 26, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.